Acorah Software Products - Accounts Production 16.7.461 false true true 31 December 2023 1 January 2023 false 10 December 2025 1 January 2024 31 December 2024 31 December 2024 07732039 Suhelahmed Bhutawala Grigorios Siokas iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 07732039 frs-core:CurrentFinancialInstruments frs-core:WithinOneYear 2024-12-31 07732039 frs-core:Non-currentFinancialInstruments frs-core:BetweenOneFiveYears 2024-12-31 07732039 2023-12-31 07732039 2024-12-31 07732039 2024-01-01 2024-12-31 07732039 frs-core:CurrentFinancialInstruments 2024-12-31 07732039 frs-core:Non-currentFinancialInstruments 2024-12-31 07732039 frs-core:BetweenOneFiveYears 2024-12-31 07732039 frs-core:FurnitureFittings 2024-01-01 2024-12-31 07732039 frs-core:LandBuildings 2024-12-31 07732039 frs-core:LandBuildings 2024-01-01 2024-12-31 07732039 frs-core:LandBuildings 2023-12-31 07732039 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2024-01-01 2024-12-31 07732039 frs-core:PlantMachinery 2024-12-31 07732039 frs-core:PlantMachinery 2024-01-01 2024-12-31 07732039 frs-core:PlantMachinery 2023-12-31 07732039 frs-core:WithinOneYear 2024-12-31 07732039 frs-core:ShareCapital 2024-12-31 07732039 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31 07732039 frs-bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 07732039 frs-bus:FilletedAccounts 2024-01-01 2024-12-31 07732039 frs-bus:SmallEntities 2024-01-01 2024-12-31 07732039 frs-bus:Audited 2024-01-01 2024-12-31 07732039 frs-bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 07732039 frs-bus:Director1 2024-01-01 2024-12-31 07732039 frs-bus:Director2 2024-01-01 2024-12-31 07732039 frs-countries:EnglandWales 2024-01-01 2024-12-31 07732039 frs-core:CurrentFinancialInstruments frs-core:WithinOneYear 2023-12-31 07732039 frs-core:Non-currentFinancialInstruments frs-core:BetweenOneFiveYears 2023-12-31 07732039 2022-12-31 07732039 2023-12-31 07732039 2023-01-01 2023-12-31 07732039 frs-core:CurrentFinancialInstruments 2023-12-31 07732039 frs-core:Non-currentFinancialInstruments 2023-12-31 07732039 frs-core:BetweenOneFiveYears 2023-12-31 07732039 frs-core:WithinOneYear 2023-12-31 07732039 frs-core:ShareCapital 2023-12-31 07732039 frs-core:RetainedEarningsAccumulatedLosses 2023-12-31
Registered number: 07732039
Decahedron Ltd
Financial Statements
For The Year Ended 31 December 2024
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2—5
Page 1
Balance Sheet
Registered number: 07732039
2024 2023
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 24,218 30,320
24,218 30,320
CURRENT ASSETS
Stocks 5 246,596 230,257
Debtors 6 1,222,468 1,320,718
Cash at bank and in hand 6,792 34,947
1,475,856 1,585,922
Creditors: Amounts Falling Due Within One Year 7 (2,926,736 ) (2,589,899 )
NET CURRENT ASSETS (LIABILITIES) (1,450,880 ) (1,003,977 )
TOTAL ASSETS LESS CURRENT LIABILITIES (1,426,662 ) (973,657 )
Creditors: Amounts Falling Due After More Than One Year 8 (36,623 ) (38,154 )
NET LIABILITIES (1,463,285 ) (1,011,811 )
CAPITAL AND RESERVES
Called up share capital 11 1,512,590 1,512,590
Profit and Loss Account (2,975,875 ) (2,524,401 )
SHAREHOLDERS' FUNDS (1,463,285) (1,011,811)
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Suhelahmed Bhutawala
Director
10/12/2025
The notes on pages 2 to 5 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Decahedron Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 07732039 . The registered office is Unit 14 Spire Green Centre, Harlow, Essex, CM19 5TR.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the
historical cost convention.
These financial statements have been prepared in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' ('FRS 102') and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements have been prepared under the historical cost convention. The principal account policies adopted are set out below.
2.2. Going Concern Disclosure
The company is dependent upon the continued financial support of its parent company. Cosmos Health Inc. Therefore, the going concern basis of the company is inherently linked to that of the Cosmos Health Inc group.
Notwithstanding, the conditions described above, at the date of approval of these financial statements the directors have a reasonable expectation that the group, and therefore the company, has adequate resources to continue in operational existence and meet its liabilities as they fall due for the foreseeable future, being a period of at least twelve months from the date of these financial statements were approved. 
2.3. Turnover
The company’s turnover represents the total invoiced value of goods supplied during the year, excluding value added tax. Turnover is derived from the sale of vitamin and dietary supplement products through e-commerce platforms, primarily Amazon and TikTok Shop.All sales are made directly to end customers, with revenue recognised at the point of delivery when the significant risks and rewards of ownership have transferred to the customer, in accordance with the recognition criteria of UK GAAP (FRS 102).
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Leasehold Straight line over the life of the asset
Fixtures & Fittings 20% on reducing balance
2.5. Leasing and Hire Purchase Contracts
Assets obtained under finance leases are capitalised as tangible fixed assets. Assets acquired under finance leases are depreciated over the shorter of the lease term and their useful lives. Assets acquired under hire purchase contracts are depreciated over their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the company. Obligations under such agreements are included in the creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to the profit and loss account so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.
Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged to the profit and loss account as incurred.
2.6. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.
Page 2
Page 3
2.7. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 5 (2023: 5)
5 5
4. Tangible Assets
Land & Buildings Plant & Machinery etc. Total
£ £ £
Cost
As at 1 January 2024 4,444 92,786 97,230
As at 31 December 2024 4,444 92,786 97,230
Depreciation
As at 1 January 2024 4,444 62,466 66,910
Provided during the period - 6,102 6,102
As at 31 December 2024 4,444 68,568 73,012
Net Book Value
As at 31 December 2024 - 24,218 24,218
As at 1 January 2024 - 30,320 30,320
5. Stocks
2024 2023
£ £
Stock 246,596 230,257
6. Debtors
2024 2023
£ £
Due within one year
Trade debtors 1,163,517 1,220,764
Other debtors 48,451 89,454
1,211,968 1,310,218
Due after more than one year
Other debtors 10,500 10,500
1,222,468 1,320,718
Page 3
Page 4
7. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Net obligations under finance lease and hire purchase contracts 1,531 1,531
Trade creditors 84,310 219,380
Bank loans and overdrafts 2,286 5,000
Amounts owed to group undertakings 2,706,424 2,216,024
Other creditors 60,552 40,253
Taxation and social security 71,633 107,711
2,926,736 2,589,899
8. Creditors: Amounts Falling Due After More Than One Year
2024 2023
£ £
Net obligations under finance lease and hire purchase contracts 765 2,296
Bank loans 35,858 35,858
36,623 38,154
9. Loans
An analysis of the maturity of loans is given below:
2024 2023
£ £
Amounts falling due within one year or on demand:
Bank loans 2,286 5,000
2024 2023
£ £
Amounts falling due between one and five years:
Bank loans 35,858 35,858
10. Obligations Under Finance Leases and Hire Purchase
2024 2023
£ £
The future minimum finance lease payments are as follows:
Not later than one year 1,531 1,531
Later than one year and not later than five years 765 2,296
2,296 3,827
2,296 3,827
11. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 1,512,590 1,512,590
Page 4
Page 5
12. Related Party Disclosures
The parent undertaking and ultimate holding company is Cosmos Health Inc, incorporated in the United States of America at 141 West Jackson Blvd., Suite 4236, Chicago, IL 60604.
This is the smallest and largest group in which the results of the company are consolidated and are available from 141 West Jackson Blvd., Suite 4236, Chicago, IL 60604, United States of America.
13. Subsequent Event Disclosure
After the year-end, on 24 November 2025, the Company completed a loan capitalisation transaction with its parent company Cosmos Health Inc. An outstanding intercompany loan of £1,850,000 was fully settled through the issue of 1,850,000 Ordinary A shares of £1.00 each.
This transaction reflects corporate decisions made after the reporting date, and therefore constitutes a non-adjusting subsequent event under FRS 102/IAS 10. The financial statements for the year ended 31 December 2024 have not been adjusted as the conditions leading to the transaction did not exist at the balance sheet date.
14. Audit Information
The auditor's report on the accounts of Decahedron Ltd for the year ended 31 December 2024 was unqualified.
The auditor's report was signed by Lorraine Curtis (Senior Statutory Auditor) for and on behalf of Nordens Audit Limited , Statutory Auditor.
Nordens Audit Limited
The Retreat
406 Roding Lande South
Woodford Green
Essex
IG8 8EY
Page 5